We are live on ! Find out more
NAGE icon

Niagen Bioscience

64 hedge funds and large institutions have $40.9M invested in Niagen Bioscience in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

249% more capital inflows, than outflows

Capital inflows: $3.64M | Capital outflows: $1.04M

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

1.03% more ownership

Funds ownership: 16.3% → 17.33% (+1%)

0% more funds holding

Funds holding: 64 → 64 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
64
Holders Change
–
Holders Change %
0%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
20
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NAGE Hedge Fund Activity: Q3 2018 in Review

64 of the 4,393 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2018, worth a combined $40.9M — up 23% from $33.2M a quarter earlier.

Fund positioning in NAGE was balanced in Q3 2018: 7 funds opened new positions, 7 closed out, 20 added to existing stakes and 12 trimmed.

The largest buyer was Northern Trust, adding an estimated $1.23M. The largest seller was Wells Fargo, cutting an estimated $338K.

  • 64 institutional investors held Niagen Bioscience (NAGE) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $40.9M of Niagen Bioscience stock for Q3 2018, up 23% quarter-over-quarter.
  • 7 funds opened new Niagen Bioscience positions in Q3 2018 and 7 closed out, a net change of 0 holders.
  • The largest Niagen Bioscience buyer in Q3 2018 was Northern Trust, an estimated $1.23M added.
  • The largest Niagen Bioscience seller in Q3 2018 was Wells Fargo, an estimated $338K sold.

Based on aggregated 13F filings for Q3 2018.